Besides cancer immunotherapy, it is worth mentioning that BTLA/HVEM axis is also likely to emerge as a critical player in other diseases, including sepsis [92, 108–110], neuroinflammation [111], infectious [112–114] and autoimmune diseases [115–119]. The gene discussed is TNFRSF14; the disease is Sepsis.